Insider · CIK 0001201427

BRISTOW DUKE K

Reports to the SEC for 2 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001201427

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-10-10	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−3,171 sh	$11.77	−$37.3K	9,248
2013-10-09	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−1,100 sh	$11.70	−$12.9K	12,419
2013-10-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−22.6K sh	$12.24	−$276K	13,519
2013-10-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$8.19	−$41K	0
2013-10-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+17.6K sh	$7.50	+$132K	31,083
2013-10-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$8.19	+$41K	36,083
2013-10-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−17.6K sh	$7.50	−$132K	0
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$5.63	−$28.2K	0
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−32.4K sh	$12.22	−$396K	13,519
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	33,519
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+2,436 sh	$7.50	+$18.3K	45,955
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−2,436 sh	$7.50	−$18.3K	17,564
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$6.85	−$68.5K	0
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$6.66	−$33.3K	0
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$6.22	−$31.1K	0
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to buy Nonqualified stock optionsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$5.77	−$28.8K	0
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$6.85	+$68.5K	43,519
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.63	+$28.2K	18,519
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	23,519
2013-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.22	+$31.1K	28,519
2013-06-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	+3,496 sh	—	—	3,496
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	13,519
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2013-04-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−3,150 sh	$14.06	−$44.3K	11,852
2013-04-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$8.86	+$44.3K	15,002
2013-04-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non Qualified Stock OptionX Exercise of In-Money	Director	XExercise of In-Money	−5,000 sh	$8.86	−$44.3K	0
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	10,002
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	65,000
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	8,335
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	60,000
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2010-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.63	+$28.2K	55,000
2010-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2010-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	6,668
2010-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2009-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	5,001
2009-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2009-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	—	—	1,667
2009-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	$6.22	+$31.1K	50,000
2008-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	—	—	1,667
2008-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	$8.19	+$41K	45,000
2007-06-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	—	—	1,667
2007-06-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	$13.32	+$66.6K	40,000
2007-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2007-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2006-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	$8.86	+$44.3K	35,000
2006-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	$8.86	+$14.8K	1,667

Recent filings

Accepted (ET)
Oct 114
LANDEC CORP \CA\0001437749-13-012999
SEC(opens sec.gov)
Oct 24
LANDEC CORP \CA\0001437749-13-012673
SEC(opens sec.gov)

Companies

Address

C/O LANDEC CORPORATION 3603 HAVEN AVENUE

MENLO PARK, CA, 94025